157 related articles for article (PubMed ID: 25451081)
1. Disordered signaling governing ferroportin transcription favors breast cancer growth.
Chen Y; Zhang S; Wang X; Guo W; Wang L; Zhang D; Yuan L; Zhang Z; Xu Y; Liu S
Cell Signal; 2015 Jan; 27(1):168-76. PubMed ID: 25451081
[TBL] [Abstract][Full Text] [Related]
2. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract][Full Text] [Related]
3. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.
Qian Y; Yin C; Chen Y; Zhang S; Jiang L; Wang F; Zhao M; Liu S
Cell Signal; 2015 May; 27(5):934-42. PubMed ID: 25660146
[TBL] [Abstract][Full Text] [Related]
4. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.
Guo W; Zhang S; Chen Y; Zhang D; Yuan L; Cong H; Liu S
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):703-15. PubMed ID: 26201356
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.
Jiang X; Zhang C; Qi S; Guo S; Chen Y; Du E; Zhang H; Wang X; Liu R; Qiao B; Yang K; Zhang Z; Xu Y
Oncotarget; 2016 Dec; 7(51):84893-84906. PubMed ID: 27768596
[TBL] [Abstract][Full Text] [Related]
6. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
[TBL] [Abstract][Full Text] [Related]
7. Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin.
Xue D; Zhou C; Shi Y; Lu H; Xu R; He X
Oncotarget; 2016 Nov; 7(48):78804-78812. PubMed ID: 27788496
[TBL] [Abstract][Full Text] [Related]
8. Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.
Deng Z; Manz DH; Torti SV; Torti FM
Antioxid Redox Signal; 2019 Mar; 30(8):1043-1061. PubMed ID: 29061069
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.
Guo H; Lin Y; Zhang H; Liu J; Zhang N; Li Y; Kong D; Tang Q; Ma D
BMC Mol Biol; 2007 Dec; 8():110. PubMed ID: 18053161
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.
Chiabrando D; Fiorito V; Marro S; Silengo L; Altruda F; Tolosano E
Blood Cells Mol Dis; 2013 Jan; 50(1):25-30. PubMed ID: 22921471
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin Mediates Transcriptional Changes in Ferroportin mRNA in Differentiated Neuronal-Like PC12 Cells Subjected to Iron Challenge.
Helgudottir SS; Lichota J; Burkhart A; Moos T
Mol Neurobiol; 2019 Apr; 56(4):2362-2374. PubMed ID: 30027341
[TBL] [Abstract][Full Text] [Related]
13. miR-20a regulates expression of the iron exporter ferroportin in lung cancer.
Babu KR; Muckenthaler MU
J Mol Med (Berl); 2016 Mar; 94(3):347-59. PubMed ID: 26560875
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
15. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
16. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
17. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
18. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
19. Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS.
Oh CK; Park SH; Kim J; Moon Y
J Biol Chem; 2016 Sep; 291(38):19858-72. PubMed ID: 27445333
[TBL] [Abstract][Full Text] [Related]
20. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
